| Literature DB >> 22579928 |
Irina Vardya1, Kirsten Hoestgaard-Jensen, Jose Luis Nieto-Gonzalez, Zita Dósa, Kim Boddum, Mai Marie Holm, Toni D Wolinsky, Kenneth A Jones, Nils Ole Dalby, Bjarke Ebert, Kimmo Jensen.
Abstract
δ-subunit containing extrasynaptic GABA(A) receptors are potential targets for modifying neuronal activity in a range of brain disorders. With the aim of gaining more insight in synaptic and extrasynaptic inhibition, we used a new positive modulator, AA29504, of δ-subunit containing GABA(A) receptors in mouse neurons in vitro and in vivo. Whole-cell patch-clamp recordings were carried out in the dentate gyrus in mouse brain slices. In granule cells, AA29504 (1 μM) caused a 4.2-fold potentiation of a tonic current induced by THIP (1 μM), while interneurons showed a potentiation of 2.6-fold. Moreover, AA29504 (1 μM) increased the amplitude and prolonged the decay of miniature inhibitory postsynaptic currents (mIPSCs) in granule cells, and this effect was abolished by Zn²⁺ (15 μM). AA29504 (1 μM) also induced a small tonic current (12.7 ± 3.2 pA) per se, and when evaluated in a nominally GABA-free environment using Ca²⁺ imaging in cultured neurons, AA29504 showed GABA(A) receptor agonism in the absence of agonist. Finally, AA29504 exerted dose-dependent stress-reducing and anxiolytic effects in mice in vivo. We propose that AA29504 potentiates δ-containing GABA(A) receptors to enhance tonic inhibition, and possibly recruits perisynaptic δ-containing receptors to participate in synaptic phasic inhibition in dentate gyrus.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22579928 DOI: 10.1016/j.neuropharm.2012.04.023
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.250